June 19 (Reuters) - QBE Insurance (QBE) :
- SEES 1H24 GROSS WRITTEN PREMIUM IS EXPECTED TO BE $13.1B
- STRATEGIC REVIEW OF NORTH AMERICA MIDDLE-MARKET
- HAS DETERMINED IT WILL COMMENCE AN ORDERLY CLOSURE OF ITS NORTH AMERICA MIDDLE-MARKET SEGMENT
- QBE HAS DETERMINED IT WILL COMMENCE AN ORDERLY CLOSURE OF ITS NORTH AMERICA MIDDLE-MARKET SEGMENT
- WILL BEGIN NON-RENEWING MIDDLE-MARKET POLICIES ACCORDING TO APPLICABLE STATE REGULATIONS, WITH GROSS WRITTEN PREMIUM EXPECTED TO BEGIN REDUCING IN FY24
- RESTRUCTURING CHARGE OF $100M BEFORE TAX WILL BE RECORDED IN THE FY24 RESULT TO ACCOUNT FOR COSTS ASSOCIATED WITH BUSINESS CLOSURE
- CONTINUES TO EXPECT FY24 GROUP CONSTANT CURRENCY GROSS WRITTEN PREMIUM GROWTH IN MID-SINGLE DIGITS
- SEES TOTAL INVESTMENT INCOME IN FIVE MONTHS TO MAY-2024 WAS $643M, WHICH IMPROVED FROM $406M IN 1Q24
(([email protected];))
- Forums
- ASX - By Stock
- QBE
- News: QBE QBE Insurance Sees 1H24 Gross Written Premium $13.1B
QBE
qbe insurance group limited
Add to My Watchlist
1.07%
!
$21.66

News: QBE QBE Insurance Sees 1H24 Gross Written Premium $13.1B
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$21.66 |
Change
0.230(1.07%) |
Mkt cap ! $32.35B |
Open | High | Low | Value | Volume |
$21.85 | $21.85 | $21.49 | $17.54M | 811.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1023 | $21.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.67 | 474 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 85 | 21.760 |
4 | 740 | 21.750 |
5 | 459 | 21.740 |
5 | 447 | 21.730 |
11 | 1515 | 21.720 |
Price($) | Vol. | No. |
---|---|---|
21.770 | 225 | 5 |
21.780 | 824 | 7 |
21.790 | 1369 | 10 |
21.800 | 1017 | 8 |
21.810 | 1173 | 7 |
Last trade - 10.18am 22/08/2025 (20 minute delay) ? |
Featured News
QBE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online